FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

371713004: Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/15mg/1mL liquid (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1197012010 Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/15mg/1mL liquid (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1210324018 Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/15mg/1mL liquid en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    4720851000005119 carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske Is a Product containing pseudoephedrine (medicinal product) false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske Is a Product containing carbinoxamine (medicinal product) false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ethanolamine false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Carbinoxamine (substance) false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pseudoephedrine (substance) false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske Is a carbinoxaminmaleat + pseudoephedrinhydrochlorid false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Carbinoxamine maleate false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pseudoephedrine hydrochloride (substance) false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske Has manufactured dose form oral væske false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cardiovascular agent (substance) false Inferred relationship Some
    carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start